Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11993610 BCL-2 inhibitors

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 May, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 30 May, 2024
Edits made to:
Infobox (+52 properties)
‌

 US Patent 11993610 BCL-2 inhibitors

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119936100
Patent Inventor Names
Yan Lou0
Yi Chen0
Date of Patent
May 28, 2024
0
Patent Application Number
178409570
Date Filed
June 15, 2022
0
Patent Citations
‌
US Patent 7642260 Apoptosis promoters
0
‌
US Patent 7767684 Apoptosis promoters
0
‌
US Patent 7973161 Apoptosis promoters
0
‌
US Patent 8084607 Apoptosis promoters
0
‌
US Patent 8173811 Apoptosis promoters
0
‌
US Patent 8354404 Apoptosis promoters
0
‌
US Patent 8546399 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 8557983 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 8563735 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 8580794 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 8586754 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 8614318 Apoptosis promoters
0
‌
US Patent 8686136 Apoptosis promoters
0
‌
US Patent 8952157 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9006247 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9029404 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9034875 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9045420 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9045444 Apoptosis promoters
0
‌
US Patent 9045475 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9045920 Vehicle door inside handle device
0
‌
US Patent 9072748 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9073855 BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9125913 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9174982 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9303025 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9315488 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9403822 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 10377755 BCL-2 inhibitors
0
‌
US Patent 11279711 Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases
0
‌
US Patent 11365206 BCL-2 inhibitors
0
Patent Primary Examiner
‌
Sun Jae Yoo
0
CPC Code
‌
C07D 513/14
0
‌
C07D 498/04
0
‌
A61K 45/06
0
‌
A61P 37/00
0
‌
A61P 35/00
0
‌
A61P 35/04
0
‌
A61P 35/02
0
‌
A61P 3/10
0
‌
A61P 25/00
0
‌
A61P 25/18
0
‌
A61K 31/542
0
‌
A61K 31/5383
0

Find more entities like US Patent 11993610 BCL-2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.